Home › NDC Lookup › RxCUI directory › RxCUI 204874

Hydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML Ophthalmic Suspens... — RxCUI 204874

Name: Hydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML Ophthalmic Su… (RxCUI 204874)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 204874 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI204874

Official nameHydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML Ophthalmic Suspension

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known ashydrocortisone 1 % / neomycin (neomycin sulfate) 0.35 % / polymyxin B (polymyxin B sulfate) 10,000 UNT/ML Ophthalmic Suspension; neomycin sulfate 0.35 % / polymyxin B sulfate 10,000 UNT/ML / hydrocortisone 1 % Ophthalmic Suspension

FDA products mapped1

Package NDCs mapped1

Reported Medicaid activity (SDUD)1,270 prescriptions · 19 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Hydrocortisone Rectal: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

This is a corticosteroid enema used specifically for ulcerative colitis that affects the lower part of your colon — the rectum and the left side. Rather than treating the whole bod...
What exactly is this enema treating — is it the same as regular colitis medicine?
Many people notice symptoms like diarrhea and bleeding improving within 3 to 5 days. That said, the actual healing of the colon lining often takes longer to show up — sometimes wee...
How long do I need to use it before it starts working?

📖 Read our full Hydrocortisone Rectal guide →

🕸️ Concept Web — How Hydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / p... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Hydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML Ophthalmic Suspension RxCUI 204874 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 4

The active substance itself — no strength, form, or brand attached yet.
- Hydrocortisone 5492 IN
- Neomycin 7299 IN
- Polymyxin B 8536 IN
- Hydrocortisone / neomycin / polymyxin B 217627 MIN
Dose forms 4

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Hydrocortisone / neomycin / polymyxin B Ophthalmic Suspension 374762 SCDF
- Hydrocortisone / neomycin / polymyxin B Ophthalmic Product 1163422 SCDG
- Ophthalmic Suspension 316964 DF
- Ophthalmic Product 1151135 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Hydrocortisone 10 MG/ML 316057 SCDC
- Neomycin 3.5 MG/ML 316332 SCDC
- Polymyxin B 10000 UNT/ML 316526 SCDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Hydrocortisone 10 MG/ML SCDC · 316057
Neomycin 3.5 MG/ML SCDC · 316332
Polymyxin B 10000 UNT/ML SCDC · 316526
Hydrocortisone / neomycin / polymyxin B Ophthalmic Suspension SCDF · 374762
Hydrocortisone / neomycin / polymyxin B Ophthalmic Product SCDG · 1163422

📦 FDA Products & Package NDCs

1 product · 1 package NDC

1 package NDC map to RxCUI 204874 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
61314-0641-75	7.5 mL in 1 BOTTLE, PLASTIC (61314-641-75)	Neomycin and Polymyxin B Sulfates and Hydrocortisone	Sandoz Inc	2003-05-09

Observed labelers: Sandoz Inc (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.

Per ml · median

$18.4420

Range $18.4420–$18.4420 · middle 50% $18.4420–$18.4420 · 1 NDCs

Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.